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Abstract
Introduction: An intramural duodenal hematoma is a rare but recognized complication that
usually develops after abdominal trauma, predominantly in children and young adults.
Case Presentation: we report the case of a patient that developed an intramural duodenal
hematoma after endoscopic treatment for a bleeding ulcer who also was undergoing conventional
hemodialysis for chronic renal failure associated with lupus nephritis. A hemoperitoneum and near-
total duodenal obstruction developed but spontaneously resolved with conservative treatment.
Conclusion:  clinicians should be aware of such possible complications after endoscopic
hemostasis in patients with coagulation disorders.
Introduction
Endoscopic hemostatic procedures such as local injection
of epinephrine, polidocanal and fibrin tissue adhesive
onto the mucosa, and hemoclipping are commonly used
for the treatment of bleeding ulcers, instead of the open
surgical approaches used in the past [1]. Although the
risks are usually considered minimal, there are reports
that intramural duodenal hematomas can develop as a
complication after diagnostic or therapeutic endoscopy,
especially in patients susceptible to hemorrhage such as
those with end-stage renal disease (ESRD) [1,2]. We
report here the case of a patient that developed an intra-
mural hematoma of the duodenum after endoscopic
treatment for a bleeding ulcer using epinephrine injection
and hemoclipping; the patient had end-stage renal failure
due to lupus nephritis and was undergoing hemodialysis.
Clinicians should be aware of such complications after
endoscopic hemostasis in patients with coagulation disor-
ders.
Case presentation
A 30-year-old woman complained, during a hemodialysis
session, of diarrhea and subsequent melena for one-day.
The patient was on a schedule of hemodialysis three times
a week at the dialysis unit of our hospital; she had chronic
renal failure due to lupus nephritis, and was being treated
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with oral prednisolone, 20 mg daily, for control of lupus
disease activity. In addition, the patient was usually
treated with nafamostat mesilate as a hemodialysis anti-
coagulant.
At that time, a physical examination revealed anemic con-
junctivae but no icteric sclera, abdominal tenderness or
organomegaly. The blood pressure was 150/95 mmHg,
pulse rate 88/min, and body temperature 36.4°C. Labora-
tory investigations on admission were as follows: hemo-
globin 8.4 g/dL; white blood cell count 1320/mm3;
platelet count 77,000/mm3; prothrombin 96.2% with
INR 1.02; partial thromboplastin time 68.4 seconds;
serum albumin 3.58 g/dL; serum aspartate transaminase
(AST) 15 IU/L; serum alanine transaminase (ALT) 9 IU/L;
alkaline phosphatase 123 IU/L; and total cholesterol 152
mg/dL. Hepatitis B surface antigen, hepatitis C antibody,
and HIV antibody were all negative. Since the patient had
been treated, at various times, with corticosteroids and
pulse cyclophosphamide, the C3, C4, ANA and anti-ds
DNA were normal; however, she had a positive antiplate-
let antibody test. Because of the suspicion of active gas-
trointestinal bleeding, emergency gastrofiberscopy was
performed immediately after the hemodialysis session.
Endoscopy revealed two oozing ulcers in the duodenal
wall at the duodenal bulb with exposed vessels and one
round ulcer at the high body of the lesser curvature of the
stomach. An injection of 0.2% epinephrine to a total of
2.5 mL with subsequent hemoclipping was performed for
the duodenal ulcers with active bleeding (Figure 1). The
patient was treated with intravenous administration of
omeprazole. After the endoscopic hemostasis, the patient
developed sharp epigastric pain, nausea and intermittent
vomiting. The physicians considered the symptoms were
due to the endoscopic procedure. The next day, the patient
appeared pale, with a decreased hemoglobin level to 5.8
g/dL. Follow-up endoscopy showed no further bleeding
evidence of the corresponding duodenal ulcers. Three
days after the endoscopy, progression of the anemia was
noted without hemodynamic instability; the patient
required frequent transfusions.
On the fourth day after the endoscopic treatment, the
patient had diffuse abdominal distension and tenderness
with persistent nausea and vomiting. An emergency com-
puted tomography (CT) of the abdomen revealed a 13 ×
6.5 cm mixed-density hematoma at the second and third
portions of the duodenum with compression the ampulla
of Vater, resulting in dilatation of the common bile duct
and the intrahepatic ducts (Figure 2). In addition, there
was a moderate amount of high-attenuation fluid in the
perisplenic area, paracolic gutters and pelvic cavity, indi-
cating a hemoperitoneum. Without inflammatory
changes in the peripancreatic fat, to support a diagnosis of
pancreatitis based on the CT findings, the serum amylase
level had increased from 145 IU/L (normal, < 200 IU/L)
on admission to 373 IU/L, with elevation of the serum
lipase of 694 IU/L (normal, < 200 IU/L). The serum total
and direct bilirubin values were 0.96 IU/L and 0.48 IU/L,
respectively. A repeat endoscopy showed nearly complete
obstruction of the lumen, at the site of treatment of the
duodenal ulcer, by a very large hematoma (Figure 3). A
diagnosis of duodenal obstruction, due to an intramural
duodenal hematoma with hemoperitoneum, was made
on the basis of the CT and follow-up endoscopic appear-
ance and the progression of the anemia. The development
of fever posed a therapeutic dilemma for the clinicians,
who had to rapidly decide whether to perform a surgical
evacuation or external drainage; the patient was conserva-
tively managed with intravenous omeprazole and antibi-
otics, continuous nasogastric suction, and total parenteral
nutrition. After 10 days, an upper gastrointestinal series
using gastrograffin revealed a partial obstruction at the
level of the second portion of the duodenum without def-
inite evidence of leakage (Figure 4). Total parenteral nutri-
tion was discontinued on the 14th day and the patient
was slowly and carefully given liquids and then a soft
meal. The patient was asymptomatic and was discharged
shortly thereafter. Serial CT findings 4 weeks (Figure 5)
and 12 weeks (Figure 6) after the onset of obstruction
showed progressive resolution of the hematoma.
Discussion
Intramural hematomas of the intestine usually present
due to blunt trauma to the abdomen. In 60-80% of the
reported cases the patients are children and young adults,
and over 80% of the cases have a history of abdominal
trauma [1,3,4]. An intramural hematoma of the abdomen
is most commonly observed in the duodenal wall of the
Initial endoscopic findings revealed bleeding ulcers of the  duodenum that were hemoclipped Figure 1
Initial endoscopic findings revealed bleeding ulcers of 
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gastrointestinal tract. It is believed that the hematoma
results from the bowel being crushed between the anterior
abdominal wall and the vertebral column [3,4]. Because
the duodenum is relatively fixed, it is therefore prone to
this injury if enough force is applied to the anterior
abdominal wall [4]. The rich submucosal vascular supply
of the duodenum may also contribute to the development
of a hematoma [3].
Nontraumatic intramural hematomas of the duodenum
are reported to occur in some conditions such as pancre-
CT of the abdomen demonstrates a mass with a filling defect  in the second portion of the duodenum and marked narrow- ing of the lumen of the third portion of the duodenum (A),  and the largest part of the hematoma in diameter (B) Figure 2
CT of the abdomen demonstrates a mass with a fill-
ing defect in the second portion of the duodenum 
and marked narrowing of the lumen of the third por-
tion of the duodenum (A), and the largest part of the 
hematoma in diameter (B).
Follow-up endoscopy shows a near-total obstruction of the  duodenal lumen by the hematoma Figure 3
Follow-up endoscopy shows a near-total obstruction 
of the duodenal lumen by the hematoma.
Upper gastrointestinal series with gastrograffin reveals the  hematoma compressing the second portion of the duodenum  and the partial passage of gastrograffin via a near-totally  occluded duodenal lumen without leakage outside Figure 4
Upper gastrointestinal series with gastrograffin 
reveals the hematoma compressing the second por-
tion of the duodenum and the partial passage of gas-
trograffin via a near-totally occluded duodenal lumen 
without leakage outside.Cases Journal 2009, 2:9083 http://www.casesjournal.com/content/2/1/9083
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atic diseases, use of anticoagulants, and coagulation disor-
ders [1,3-5]. Iatrogenic trauma caused by diagnostic or
therapeutic endoscopy can also lead to an intramural duo-
denal hematoma. Although a local injection with epine-
phrine could cause tissue damage, in practice this does not
appear to occur [1]. Underlying conditions, however,
require special attention. Endoscopic biopsy or hemosta-
sis may pose substantial risk to the subgroup of patients
with leukemia, lymphoma, liver cirrhosis, and chronic
renal failure [1,2,6,7].
As a manifestation secondary to the obstruction of the
ampulla of Vater, due to the duodenal hematoma, pancre-
atitis can occur [1,4]. In addition, obstruction and subse-
quent dilatation of extra- or intrahepatic biliary tracts is
probable [8]. In the present case, the serum amylase and
lipase levels were elevated above the normal range. How-
ever, serum amylase and lipase concentrations have been
reported to be moderately elevated in patients with
chronic renal failure, and thus a serum amylase concentra-
tion of three times the upper limit of normal is often con-
sidered to be normal in such patients [9]. Therefore,
interpretation of the results of the serum amylase and
lipase in patients with chronic renal failure should pro-
ceed with caution.
Whereas in the past surgical evacuation or drainage was
advised, current management of an intramural duodenal
hematoma favors a conservative approach, including
nasogastric suction and total parenteral nutrition [8,10-
12]. Because the abundant blood supply of the duodenal
wall is expected to absorb the hematoma promptly, the
size of the hematoma does not appear to be a significant
issue. Surgical management should be reserved for
patients with a suspected perforation or with severely
damaged intestines [10]. In the present patient, there may
have been a small perforation due to the evidence of a
hemoperitoneum. However, careful monitoring allowed
for successful conservative management.
Two prior cases with nontraumatic duodenal hematomas
have been reported as complications of endoscopic treat-
ment in patients with ESRD [1,2]. Those case reports did
not describe in detail the causes of the bleeding diatheses.
In fact, the pathogenesis of the hemorrhagic diathesis, in
patients with ESRD, is likely multifactorial and cannot be
explained on the basis of a single mechanism. Platelet dys-
function, anemia, dialysis, the accumulation of medica-
tions due to poor clearance, anticoagulation used during
hemodialysis, and the hemodialysis process itself play
some role in causing impaired hemostasis in patients with
ESRD [13]. In the present case there was associated coag-
ulopathy-causing factors such as platelet dysfunction,
Follow-up CT of the abdomen 4 weeks post-endoscopy  demonstrates partial regression of the hematoma Figure 5
Follow-up CT of the abdomen 4 weeks post-endos-
copy demonstrates partial regression of the 
hematoma.
Follow-up CT of the abdomen 12 weeks post-endoscopy  demonstrates the decreased size of the hematoma Figure 6
Follow-up CT of the abdomen 12 weeks post-endos-
copy demonstrates the decreased size of the 
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thrombocytopenia, anemia, use of anticoagulants, and
hemodialysis. In such cases, before an invasive procedure,
the administration of desmopressin acetate or conjugated
estrogen, achieving a hematocrit of 30%, might reduce the
risk of bleeding in patients with ESRD [13].
Conclusion
This report describes an uncommon case of intramural
hematoma of the duodenum following endoscopic
hemostasis in a patient with chronic renal failure on
maintenance hemodialysis. The onset of symptoms such
as abdominal pain and vomiting and progression of ane-
mia should suggest the possibility of complications after
endoscopy. Once the diagnosis is confirmed clinically
and/or by laboratory and imaging findings, conservative
treatment with nasogastric suction and parenteral nutri-
tion can be successfully used as treatment for hemody-
namically stable patients. Careful monitoring for the
emergence of complications after endoscopic procedures
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